The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 07, 2016

Filed:

Jun. 03, 2013
Applicant:

Abbott Laboratories, Abbott Park, IL (US);

Inventors:

Kent C. B. Stalker, San Marcos, CA (US);

Winnette S. McIntosh, San Jose, CA (US);

Dudley S. Jayasinghe, Murrieta, CA (US);

Gregory C. Orr, Escondido, CA (US);

John E. Papp, Temecula, CA (US);

Lewis B. Schwartz, Lake Forest, IL (US);

Assignee:

Abbott Laboratories, Abbott Park, IL (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61F 2/06 (2013.01); A61L 31/02 (2006.01); A61L 31/10 (2006.01); A61L 31/16 (2006.01);
U.S. Cl.
CPC ...
A61F 2/06 (2013.01); A61L 31/022 (2013.01); A61L 31/10 (2013.01); A61L 31/16 (2013.01); A61L 2300/416 (2013.01); A61L 2420/08 (2013.01);
Abstract

A drug eluting stent can include a stent body having a polymeric coating with a lipophilic and/or hydrophilic element. A drug that has a bioactivity that inhibits cell proliferation can be disposed in the polymeric coating. The drug can be present in the polymer at an amount greater than or equal to about 150 μg/cm. The polymeric coating and drug are configured to cooperate so as to form a diffusion pathway with tissue when the stent is disposed in a body lumen such that the drug preferentially diffuses into the tissue over a body fluid passing through the body lumen such that a maximum systemic blood concentration of the drug is less than about 40 ng/ml.


Find Patent Forward Citations

Loading…